Please login to the form below

Not currently logged in
Email:
Password:

celecoxib

This page shows the latest celecoxib news and features for those working in and with pharma, biotech and healthcare.

Products over pipeline in Pfizer's acquisition targets, hints CEO

Products over pipeline in Pfizer's acquisition targets, hints CEO

Most damaging to Pfizer's top-line this year was the loss of patent protection for big-selling painkiller Celebrex  (celecoxib) last December in the US, with competition already being felt

Latest news

More from news
Approximately 3 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Immunocore names CEO Immunocore names CEO

    During this time he helped bring several drugs to markets including Celebrex (celecoxib) and Relpax (eletriptan) and to establish the company in India and China.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Guide
How to embrace behavioural science principles in healthcare MR...
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...